Frenkel Ran 4
4 · Karyopharm Therapeutics Inc. · Filed Feb 21, 2020
Insider Transaction Report
Form 4
Frenkel Ran
EVP, WW Development Operations
Transactions
- Sale
Common Stock
2020-02-19$16.48/sh−2,975$49,034→ 36,066 total
Footnotes (2)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.